Author: Ken Dropiewski

Leviticus Cardio Confirms the Successful Completion of a Long-term Chronic Animal Study

PETAH TIKVA, Israel, April 10, 2018 /PRNewswire/ — Leviticus Cardio, the inventor of wireless power transfer for Left Ventricular Assisted Devices, or “LVADs”, for patients with severe cardiac issues, has announced another round of successful animal trials, well beyond periods required to demonstrate suitability for chronic conditions. The company confirms that the successful studies […]

Global Interventional Cardiology and Peripheral Vascular Device Market 2018-2023 – A $26.3 Billion Market Opportunity

DUBLIN, April 10, 2018 /PRNewswire/ — The “Interventional Cardiology and Peripheral Vascular Device Market Report: Trends, Forecast and Competitive Analysis”report has been added to ResearchAndMarkets.com’s offering.  The global interventional cardiology and peripheral vascular device market is expected to reach an estimated $26.3 billion by 2023, and it is forecast to grow at a CAGR of 5.5% from […]

Edwards Lifesciences To Host Earnings Conference Call On April 24, 2018

IRVINE, Calif., April 10, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended March 31, 2018 after the market closes on Tuesday, April 24, 2018, and will host a conference call at 5:00 p.m. […]

Recently Published CARRESS-HF Per Protocol Analysis Demonstrates Greater Fluid Reduction in Heart Failure Patients Using CHF Solutions’ Aquadex FlexFlow System

EDEN PRAIRIE, Minn., April 10, 2018 (GLOBE NEWSWIRE) — A recently published study in the European Journal of Heart Failure highlighted a per protocol analysis of the CARRESS-HF study, which demonstrated that ultrafiltration with the Aquadex Flex Flow System by CHF Solutions, Inc. (Nasdaq:CHFS) was associated with a higher cumulative fluid loss (p=0.003), […]

NobleStitch™ EL Italian Registry Data Published In EuroIntervention

ROME, April 9, 2018 /PRNewswire/ — Nobles Medical Technologies II, Inc. (NMT2) has announced the first peer-reviewed publication of data for PFO closure using the NobleStitch™ EL. The first systematic clinical experience by using the revolutionary “deviceless” technique to close Patent Foramen Ovale (PFO) has been recently published in the prestigious peer-reviewed European […]

Key Findings of the Global Prosthetic Heart Valves Market | Technavio

LONDON–(BUSINESS WIRE)–The latest market research report by Technavio on the global prosthetic heart valves market predicts a CAGR of above 12% during the period 2018-2022. The report segments the global prosthetic heart valves market by product (transcatheter heart valves, tissue heart valves, and mechanical heart valves), by end-user (hospitals and ASCs), and by geography (the Americas, EMEA, and […]

HeartSciences Showcases MyoVista® Wavelet ECG at 2018 China International Medicinal Equipment Fair (CMEF)

SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 China International Medicinal Equipment Fair (CMEF) Shanghai, China, April 11-14, 2018. CMEF has become the largest fair of medical devices, related products and services in the Asia-Pacific region. The […]

Angiograms and Angioplasty – Using your body’s vascular highway to identify and treat blockages

CHICAGO, April 9, 2018 /PRNewswire-USNewswire/ — Has your doctor prescribed an angiogram? If you are not sure what to expect, you’re not alone. The Society for Vascular Surgery angiogram information web page is the number one most-visited of all its patient information pages. What does a vascular surgeon do? In fact, says vascular […]

Phase III CardiAMP Heart Failure Trial Featured in American Heart Journal

SAN CARLOS, Calif., April 9, 2018 /PRNewswire/ — BioCardia®, Inc., [OTC: BCDA] a leader in cardiovascular regenerative medicine, today announced the publication of the Phase III CardiAMP Heart Failure Trial design paper in the American Heart Journal. Titled “The CardiAMP Heart Failure Trial: A Randomized Controlled Pivotal Trial of High Dose Autologous Bone […]

Cardiac Monitoring and Cardiac Rhythm Management Devices Market Worth USD 25.12 Billion by 2022

PUNE, India, April 9, 2018 /PRNewswire/ — According to a new market research report “Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product (ECG, Cardiac Output Monitoring, ILR), CRM [ICDs, External Defibrillator, Pacemaker (Dual Chamber Pacemaker)], End User (Home and Ambulatory, Hospital) – Global Forecast to 2022“, published by MarketsandMarkets™, the market is […]